12th Oncology Update: Advances and Controversies

  • View
    321

  • Download
    0

Embed Size (px)

Text of 12th Oncology Update: Advances and Controversies

  • 1. The University of Texas MD Anderson Cancer Center12th Oncology Update:Advances and Controversies January 1720, 2014Sheraton Steamboat Hotel Steamboat Springs, Colorado

2. EDUCATIONAL METHODSLectures - Question and Answer Sessions Case Presentations Meet the Professor SessionsEVALUATION12th Oncology Update: Advances and Controversies January 17-20, 2014 Sheraton Steamboat Hotel Steamboat Springs, Colorado GOAL The goal of this program is to provide up-to-date information to the practicing physician regarding new advances in cancer care and treatment. EDUCATIONAL OBJECTIVES After attending the conference, participants should be able to Interpret information and incorporate into treatment the best novel therapies for solid tumors including Breast, Thoracic, Genitourinary, Gastrointestinal, Gynecologic/Peritoneal Malignancies, Head & Neck Cancer and Melanoma (Knowledge, Competence, Performance, Patient Outcomes) Utilize different surgical, radiation, and systemic treatments including molecularly targeted therapies for these cancers at various stages of disease to improve patient outcomes (Knowledge, Competence, Performance, Patient Outcomes) Incorporate appropriate sequence for surgical, radiation, and chemotherapeutic intervention for patients (Knowledge, Competence, Performance, Patient Outcomes) Illustrate and implement the optimal treatment approach when given patient scenarios representing a range of stages, prognostic markers, and clinical presentations (Knowledge, Competence, Performance, Patient Outcomes) Interpret the clinical effectiveness of the different treatment modalities based upon efficacy and toxicity parameters (Knowledge, Competence, Performance, Patient Outcomes)TARGET AUDIENCE This program will be of interest to surgical oncologists, medical oncologists, radiation oncologists, diagnostic radiologists, pathologists, resident trainees, primary care physicians, advanced care practitioners, physician assistants, and nurses involved in oncologic care.A course evaluation form will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.ACCREDITATION/CREDIT DESIGNATIONThe University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 25.50 AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.ETHICS CREDITSSession VI presentations marked with an asterisk* have been designated by The University of Texas MD Anderson Cancer Center for a total of 2.50 AMA PRA Category 1 CreditsTM in medical ethics and/or professional responsibility.CME CERTIFICATES AND ATTENDANCE VERIFICATION CERTIFICATESCertificates awarding AMA PRA Category 1 CreditTM or certificates documenting attendance will be distributed to participants when an individual departs the conference. To obtain a CME certificate, physicians must submit a completed evaluation questionnaire and a CME Verification Form. Upon request, a record of attendance (certificate) will be provided on-site to other health care professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.CONFERENCE CHAIRMAN Merrick I. Ross, MD Professor, Surgical Oncology MD AndersonMD ANDERSON ORGANIZING COMMITTEE Rae Brana Reynolds, RN, MSN Manager, Mid-Level Provider, Surgical Oncology Cynthia A. Scott Office Manager, Surgical Oncology Constance Tierney, CMP Manager, CME/Conference Management 3. ProgramSaturday, January 18, 2014 6:30 a.m. Registration/Continental BreakfastSession II Melanoma Moderator: Merrick I. Ross, MDFriday, January 17, 2014 3:005:00 p.m. RegistrationSession I Thoracic Oncology Moderator: Stephen G. Swisher, MD 5:00 p.m. Current Recommendations for Lung Cancer Screening: Are We Making Any Progress? Stephen G. Swisher, MD Treatment of Primary Lung Cancer: Surgery or Stereotactic Radiation What About the Mediastinum? David C. Rice, MD Update on the Battle Trial: Are We Winning Any Battles? John V. Heymach, MD Treating Lung Cancer with Immunotherapy and Radiation James Welsh, MD Minimally Invasive Approaches to Esophageal Cancer Wayne L. Hofstetter, MD Question and Answer/Case Presentations All Session FacultyKeynote Presentatons: Cancer Immunotherapy: Checkpoint Inhibition, Melanoma and Beyond Patrick Hwu, MD 8:00-10:00 p.m. Welcome ReceptionPrognostic Markers and Staging: Whats New? Jeffrey E. Gershenwald, MD Current Status of Adjuvant Therapy: Any Changes On the Horizon? Merrick I. Ross, MD Treatment of Stage IV Disease: The Art and Science of Decision Making Patrick Hwu, MD The conference will begin with registration from 3:00-5:00 p.m. on Friday, January 17, 2014 followed by a session from 5:00-8:00 p.m. and a Welcome Reception from 8:00-10:00 p.m. All other sessions will run from 7:00 a.m.Noon and 4:307:30 p.m. on January 18-20, 2014.7:00 Oncolytic Immunotherapy: Real Systemic Impact or Just Another Intra-Lesional Therapy? Robert H. Andtbacka, MD Reconstruction After Definitive Surgical Treatment David M. Adelman, MD Question and Answer/Case Presentations All Session Faculty9:30Break 10:00Meet the Professor Melanoma Surgical and Medical OncologistsNoonSession AdjournsSession III Breast Cancer Moderator: Kelly K. Hunt, MD 4:30 p.m. The Art and Science of Genetic Counselng in Breast Cancer Jennifer Litton, MD Current Controversies in the Management of DCIS Kelly K. Hunt, MD Selective Use of Adjuvant Therapy: Have the New Markers Helped? Funda Meric-Bernstam, MD Update on Triple Negative and Inflammatory Breast Cancer Jennifer Litton, MD Recurrent HER-2 Breast Cancer: Beyond Trastuzimab Vicente Valero, MD Cancer Vaccines: Is There a Future? Elizabeth A. Mittendorf, MD Question and Answer/Case Presentations All Session Faculty Keynote Presentation: Molecular Prognostic and Predictive Markers: Is Personalized Therapy Around the Corner? Funda Meric-Bernstam, MD 7:30 p.m.Session Adjourns 4. Sunday, January 19, 2014 6:30 a.m. Registration/Continental BreakfastSession IV Urology Moderator: Christopher G. Wood, MD 7:00 a.m. Management of the Primary Tumor in Advanced Prostate Cancer Brian F. Chapin, MD Localized Prostate Cancer: Who Really Needs Treatment? Neema Navai, MDRobotic Assisted Laparoscopic Radical Cystectomy with Intracorporeal Diversion: Fact, Fad, or Fantasy? Jay B. Shah, MD Controversies in the Management of Stage 1 Non-Seminomatous Testicular Cancer Jose A. Karam, MD Is there a Role for Neoadjuvant Therapy in the Management of Locally Advanced Renal Cell Carcinoma? Christopher G. Wood, MDQuestion and Answer/Case Presentations All Session Faculty 9:30Break 10:00Meet the Professor Urology FacultyNoon Session AdjournsSession V GI Cancer Moderator: Robert A. Wolff, MD 4:30 p.m. Systemic Therapy for Pancreas Cancer: Neo-Adjuvant or Adjuvant? Robert A. Wollf, MD Xenograft Models in Pancreas Cancer: Impact on Future Therapies Jason B. Fleming, MD Colon Cancer Prevention: Any Progress Made? Patrick Lynch, MD, JD Radiation Therapy for Rectal Cancer: Routine or Selective Use? Christopher Crane, MD Hepatocellular Cancer: Still a Death Sentence? Steven A. Curley, MD Question and Answer/Case Presentations All Session FacultyKeynote Presentation: Proton Therapy: Expensive Gimmick or Real Benefit? GU: Andrew K. Lee, MD Head & Neck: Steven J. Frank, MD 7:30 p.m.Session AdjournsMonday, January 20, 2014 6:30 a.m. Registration/Continental BreakfastSession VI Outcomes and Ethics Moderator: Merrick I. Ross, MD 7:00 a.m. Outcome Parameters in Cancer Care* Karl Y. Bilimoria, MD Quality of Life Assessment in Treating Patients with Melanoma and Breast Cancer* Janice N. Cormier, MD Palliative Surgery: How Do We Measure Success?* Brian D. Badgwell, MD Cervical Cancer Vaccine: Efficacy and Should it be Mandatory? Kathleen M. Schmeler, MD Health Legislation/Policy Updates TBD Question and Answer All Session Faculty Keynote Presentation: Update on Retroperitoneal Sarcomas: From Bench Research to the Patient Raphael E. Pollock, MD 9:30Break 10:00 Meet The Professor Sarcoma Faculty Noon Session AdjournsSession VII Head and Neck/Brain Moderator: Michael E. Kupferman, MD 4:30 p.m. Epidemiology of HPV and Cancer Erich M. Sturgis, MD Update on HPV Related Head and Neck Cancer Michael E. Kupferman, MD Multidisciplinary Approach to Advanced Thyroid Cancer Jeffrey E. Lee, MD Management of Metastatic Brain Tumors: Surgery or Gamma Knife? Jeffrey Weinberg, MD Question and Answer All Session FacultySession VIII Gynecologic/Peritoneal Malignancies Moderator: Michael Frumovitz, MD Using Social Media to Perform Research in Rare Tumors Jennifer K. Burzawa, MD Multidisciplinary Management of Ovarian Cancer Michael Frumovitz, MD Peritoneal Perfusion: Appendiceal Cancer and Beyond Richard Royal, MD Question and Answer/Case Presentations All Session Faculty 7:30 p.m. Conference Adjournment 5. MD AndersonFaculty David M. Adelman, MD Assistant Professor Plastic SurgeryJeffrey E. Lee, MD Chair & Professor Surgical OncologyBrian D. Badgwell, MD Assistant Professor Surgical OncologyJennifer Litton, MD Assistant Professor Breast Medical OncologyJennifer K. Burzawa, MD Assistant Professor Gynecologic Oncology Reproductive MedicinePatrick M. Lynch, MD, JD Professor, Gastroenterology Hepatology & NutritionBrian F. Chapin, MD Assistant Professor Urology Janice N. Cormier, MD Professor Surgical Oncology Christopher Crane, MD Profe